第347号指南——临界可存活胎儿的产科管理
本指南由加拿大妇产科医师学会制定,目标人群为临界可存活(目前定义为25+6周前)可能出现分娩的孕妇,适用者为参与此类产科管理的临床医生。指南基于Medline、EMBASE和Cochrane数据库检索的文献,经共识会议制定声明,采用GRADE方法分级证据质量。内容涵盖母体转运与咨询、产前糖皮质激素和硫酸镁给药、胎心监护及分娩方式考虑。指南指出文献提示产科干预可改善新生儿结局,若计划积极复苏,则应考虑积极的产科干预;咨询应采用多学科方法。
要点
- 临界可存活目前定义为25+6周前,目标人群为在此阶段可能出现分娩的孕妇。
- 咨询应采用多学科方法,涉及母胎医学、新生儿科、围产期护理、患者倡导和伦理等领域。
- 文献提示产科干预可改善新生儿结局;若计划积极复苏,则应考虑积极的产科干预。
- 管理内容包括母体转运与咨询、产前糖皮质激素和硫酸镁给药、胎心监护及分娩方式考虑。
- 证据质量采用GRADE框架分级,指南发布5年后将审查证据以决定是否更新。
适用人群与场景
- 可能出现分娩的临界可存活(目前定义为25+6周前)孕妇。
- 适用者为参与此类产科管理的临床医生,包括母胎医学、新生儿科、围产期护理、患者倡导和伦理领域人员。
诊断标准与关键阈值
- 临界可存活目前定义为25+6周前。
处置流程与药物剂量
- 咨询应采用多学科方法。
- 管理内容包括母体转运与咨询。
- 管理内容包括产前糖皮质激素给药。
- 管理内容包括硫酸镁给药。
- 管理内容包括胎心监护。
- 管理内容包括分娩方式的考虑。
- 若计划积极复苏,则应考虑积极的产科干预。
研究设计与关键结果
- 本指南由加拿大妇产科医师学会制定,采用GRADE方法分级证据质量,经共识会议制定声明。
- 文献提示产科干预可改善新生儿结局。
- 若计划积极复苏,则应考虑积极的产科干预。
证据类型、等级与局限
- 证据类型:指南,采用GRADE框架分级证据质量。
- 证据来源:Medline、EMBASE和Cochrane数据库检索,关键词包括极度早产、临界可存活、早产、妊娠、产前糖皮质激素、分娩方式。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对临界可存活(25+6周前)可能出现分娩的孕妇,应采用多学科方法进行咨询。
- 若计划积极复苏,则应考虑积极的产科干预。
指南或共识出处
- 指南名称:第347号指南——临界可存活胎儿的产科管理。
- 发布机构:加拿大妇产科医师学会(Society of Obstetricians and Gynaecologists of Canada)。
- 赞助:加拿大妇产科医师学会和Sunnybrook健康科学中心妇女与婴儿项目资助。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: The primary objective of this guideline was to develop consensus statements to guide clinical practice and recommendations for obstetric management of a pregnancy at borderline viability, currently defined as prior to 25+6 weeks.
INTENDED USERS: Clinicians involved in the obstetric management of women whose fetus is at the borderline of viability.
TARGET POPULATION: Women presenting for possible birth at borderline viability.
EVIDENCE: This document presents a summary of the literature and a general consensus on the management of pregnancies at borderline viability, including maternal transfer and consultation, administration of antenatal corticosteroids and magnesium sulfate, fetal heart rate monitoring, and considerations in mode of delivery. Medline, EMBASE, and Cochrane databases were searched using the following keywords: extreme prematurity, borderline viability, preterm, pregnancy, antenatal corticosteroids, mode of delivery. The results were then studied, and relevant articles were reviewed. The references of the reviewed studies were also searched, as were documents citing pertinent studies. The evidence was then presented at a consensus meeting, and statements were developed.
VALIDATION METHODS: The content and recommendations were developed by the consensus group from the fields of Maternal-Fetal Medicine, Neonatology, Perinatal Nursing, Patient Advocacy, and Ethics. The quality of evidence was rated using criteria described in the Grading of Recommendations Assessment, Development and Evaluation methodology framework (reference 1). The Board of the Society of Obstetricians and Gynaecologists of Canada approved the final draft for publication.
METHODS: The quality of evidence was rated using the criteria described in the Grading of Recommendations, Assessment, Development, and Evaluation methodology framework. The interpretation of strong and weak recommendations is described later. The Summary of Findings is available upon request.
BENEFITS, HARMS, AND COSTS: A multidisciplinary approach should be used in counselling women and families at borderline viability. The impact of obstetric interventions in the improvement of neonatal outcomes is suggested in the literature, and if active resuscitation is intended, then active obstetric interventions should be considered.
GUIDELINE UPDATE: Evidence will be reviewed 5 years after publication to decide whether all or part of the guideline should be updated. However, if important new evidence is published prior to the 5-year cycle, the review process may be accelerated for a more rapid update of some recommendations.
SPONSORS: This guideline was developed with resources funded by the Society of Obstetricians and Gynaecologists of Canada and the Women and Babies Program at Sunnybrook Health Sciences Centre.
参考来源
- Ladhani NNN, Chari RS, Dunn MS, et al. No. 347-Obstetric Management at Borderline Viability. J Obstet Gynaecol Can. 2017. PMID: 28859764. doi:10.1016/j.jogc.2017.03.108
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。